Zydus Receives US Approval for Schizophrenia Generic Medicine

Zydus Lifesciences Ltd announced that it has been granted final approval by the FDA to produce paliperidone extended-release tablets in doses of 1.5 mg, 3 mg, 6 mg, and 9 mg. Paliperidone extended-release tablets are prescribed for treating...

Explosion-Proof Safety in Pharmaceutical Plants: Key Design Strategies to Protect Your Facility

In pharmaceutical plant design, explosion-proof safety management is a critical factor for ensuring safe and efficient operations. Given that pharmaceutical production often involves large quantities of flammable and explosive chemicals.

Amneal Pharmaceuticals to Funnel up to USD 200 Million in India

Amneal Pharmaceuticals, a US company, announced plans to pour USD 200 million (around Rs 1,680 crore) into India for constructing two new manufacturing units in Ahmedabad within the next four to five years. The company announced plans for two new...

Emcure Pharma and Gilead Sciences Team up to produce HIV prevention drug

Emcure Pharmaceuticals announced a royalty-free voluntary licensing agreement with Gilead Sciences Ireland UC, a subsidiary of the California-based Gilead Sciences, to manufacture and supply generic versions of lenacapavir, the antiretroviral...

CCI Approves Rs 13,630-cr Mankind Pharma-Bharat Serums Vaccines deal

The Competition Commission of India (CCI) gave approval to Mankind Pharma's acquisition of Bharat Serums and Vaccines for Rs 13,630 crore. Mankind Pharma, a publicly traded company, is involved in creating, producing, and selling a wide variety of...

Dr Reddy's Funnels USD 620 Million in Switzerland subsidiary

Drug manufacturer Dr Reddy's Laboratories Ltd has invested $620 million into its wholly-owned branch, Dr Reddy’s Laboratories SA, Switzerland (DRL SA). This investment is consistent with the company's previous board-approved decision to invest up...

Takeda Secures Japanese Approval to manufacture Fruzaqla

Takeda has been approved by the Japanese Ministry of Health, Labour and Welfare (MHLW) to produce and sell Fruzaqla capsules 1mg/5mg (fruquintinib), an oral inhibitor of VEGFR-1, -2, and -3, for advanced or recurring colorectal cancer treatment...

Zydus Lifesciences to acquire Sterling Biotech's API biz for Rs 84 crore

Zydus Lifesciences Ltd announced that it will acquire Sterling Biotech's 'Target Business', which is principally engaged in the manufacturing process of fermentation-based active pharmaceutical ingredients products, as well as a production facility..

Max Healthcare acquires Jaypee Healthcare For 1,660 crore

Max Healthcare has announced a strategic partnership with Lakshdeep Group to obtain a majority share in Jaypee Healthcare, which is currently in Corporate Insolvency Resolution Process (CIRP). The purchase is valued at Rs 1,660 crore in terms of...

Eli Lilly Funds $1.8 bln in Ireland sites to boost obesity drug production

Eli Lilly announced that it will invest $1.8 billion in two manufacturing facilities in Ireland to increase production of its highly popular obesity medication and a recently approved treatment for Alzheimer's disease. The funding is a...